Pharmacotherapy - add-on therapies

被引：0
作者：
不详
机构：
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2005年 / 173卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S37 / S38
页数：2
相关论文
共 20 条
[1]   One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma [J].
Bensch, G ;
Berger, WE ;
Blokhin, BM ;
Socolovsky, AL ;
Thomson, MH ;
Till, MD ;
Castellsague, J ;
Della Cioppa, G .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 89 (02) :180-190
[2]  
Boulet L P, 2001, Can Respir J, V8 Suppl A, p5A
[3]  
Boulet LP, 1999, CAN MED ASSOC J, V161, pS1
[4]   Salmeterol in paediatric asthma [J].
Byrnes, C ;
Shrewsbury, S ;
Barnes, PJ ;
Bush, A .
THORAX, 2000, 55 (09) :780-784
[5]   Montelukast for chronic asthma in 6- to 14-year-old children - A randomized, double-blind trial [J].
Knorr, B ;
Matz, J ;
Bernstein, JA ;
Nguyen, H ;
Seidenberg, BC ;
Reiss, TF ;
Becker, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1181-1186
[6]   Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years [J].
Knorr, B ;
Franchi, LM ;
Bisgaard, H ;
Vermeulen, JH ;
LeSouef, P ;
Santanello, N ;
Michele, TM ;
Reiss, TF ;
Nguyen, HH ;
Bratton, DL .
PEDIATRICS, 2001, 108 (03) :E48
[7]   EFFICACY AND SAFETY OF SALMETEROL IN CHILDHOOD ASTHMA [J].
LENNEY, W ;
PEDERSEN, S ;
BONER, AL ;
EBBUTT, A ;
JENKINS, MM .
EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (12) :983-990
[8]   Quality of life in pediatric asthma patients treated with salmeterol and impact on the daily activities of their parents [J].
Mahajan, P ;
Stahl, E ;
Arledge, T .
PEDIATRIC ASTHMA ALLERGY & IMMUNOLOGY, 1998, 12 (01) :21-28
[9]   LONG-TERM CIRCADIAN EFFECTS OF SALMETEROL IN ASTHMATIC-CHILDREN TREATED WITH INHALED CORTICOSTEROIDS [J].
MEIJER, GG ;
POSTMA, DD ;
MULDER, PGH ;
VANAALDEREN, WMC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) :1887-1892
[10]  
RUSSELL G, 1995, ANN ALLERG ASTHMA IM, V75, P423
12